Search

Author/Creator Salazar, Ruth

1. Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial. Issue 9 (September 2022)

Authors:
Somaiah, Neeta; Conley, Anthony P; Parra, Edwin Roger; Lin, Heather; Amini, Behrang; Solis Soto, Luisa; Salazar, Ruth; Barreto, Carmelia; Chen, Honglei; Gite, Swati; Haymaker, Cara; Nassif, Elise F; Bernatchez, Chantale; Mitra, Akash; Livingston, John Andrew; Ravi, Vinod; Araujo, Dejka M; Benjami...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 9(2022)
Page Start:
1156
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Issue 11 (November 2017)

Authors:
Tawbi, Hussein A; Burgess, Melissa; Bolejack, Vanessa; Van Tine, Brian A; Schuetze, Scott M; Hu, James; D'Angelo, Sandra; Attia, Steven; Riedel, Richard F; Priebat, Dennis A; Movva, Sujana; Davis, Lara E; Okuno, Scott H; Reed, Damon R; Crowley, John; Butterfield, Lisa H; Salazar, Ruth; Rodriguez-...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 11(2017:Nov.)
Page Start:
1493
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search